Almost two-thirds of Americans with Alzheimer’s disease are women. In the Alzheimer’s disease research field, there is an interest in understanding the sex-specific differences in the risk and development of this disease. Dr. Michelle Mielke joins to discuss some of these differences as well as how pregnancy and menopause might affect cognition.
Guest: Michelle Mielke, PhD, Mayo Clinic Rochester
How does hormone replacement therapy affect a woman’s risk for developing Alzheimer’s disease? Dr. Carey Gleason, a researcher at the Wisconsin Alzheimer’s Disease Research Center, joins us to offer her insight on menopausal hormone therapy and the many factors patients and their physicians should consider in the decision-making process.
Guest: Carey Gleason, PhD, Clinical Psychology, Associate Professor and Researcher, Wisconsin Alzheimer’s Disease Research Center
In this episode, we’re fortunate enough to be joined by Dr. Sanjay Asthana, the director and founder of the Wisconsin Alzheimer’s Disease Research Center. Dr. Asthana has published extensive research in the field of hormones and brain health and will be discussing some of his work, which looks at the gender differences that exist in Alzheimer’s disease.